ORCiD
Nejat Düzgüneş: 0000-0001-6159-1391
Department
Biomedical Sciences
Document Type
Article
Publication Title
Gene Therapy
ISSN
0969-7128
Volume
5
Issue
7
DOI
10.1038/sj.gt.3300674
First Page
955
Last Page
964
Publication Date
1-1-1998
Abstract
Potential problems with the use of viral vectors for gene therapy necessitate the development of efficient nonviral vectors. The association of transferrin, or the pH-sensitive peptide GALA, with cationic liposomes composed of 1,2-dioleoyl-3-(trimethylammonium) propane and its equimolar mixture with dioleoylphosphatidylethanolamine, under conditions where the liposome/DNA complex is negatively charged, drastically increased luciferase expression from pCMVluc. The percentage of cells transfected, measured by β-galactosidase expression, was also increased by about 10-fold. The zeta potential of the ternary complexes was lower than that of the liposome/DNA complexes. Transfection activity of positively charged complexes was also enhanced by association with transferrin, GALA or the influenza hemagglutinin N terminal peptide HA-2, but to a smaller extent compared with the negatively charged complexes. The enhancement of gene delivery by transferrin or GALA was not affected significantly by the presence of serum and did not cause significant cytotoxicity. Our results indicate that negatively charged ternary complexes of cationic liposomes, DNA and transferrin, or fusigenic peptides, can facilitate efficient transfection of cultured cells, and that they may alleviate the drawbacks of the use of highly positively charged complexes for gene delivery in vivo.
Recommended Citation
Simões, S.,
Slepushkin, V.,
Caspar, R.,
Pedroso de Lima, M. C.,
&
Düzgüneş, N.
(1998).
Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides.
Gene Therapy, 5(7), 955–964.
DOI: 10.1038/sj.gt.3300674
https://scholarlycommons.pacific.edu/dugoni-facarticles/628
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.